Chinese General Practice ›› 2022, Vol. 25 ›› Issue (08): 1021-1026.DOI: 10.12114/j.issn.1007-9572.2021.01.045
Special Issue: 儿科最新文章合集
• Latest Developments • Previous Articles
Novel Developments in the Relationship of Gut Microbiota and Immune Regulation with Childhood Asthma
1. Ministry of Education Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China
2. Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China
*Corresponding author:ZHAO Xin,Assistant professor;E-mail:xinaw26@tju.edu.cn
Received:
2021-09-11
Revised:
2021-11-25
Published:
2022-03-15
Online:
2022-03-02
通讯作者:
赵鑫
基金资助:
CLC Number:
CUI Tianyi, LIU Jiarui, LYU Bin, GAO Xiumei, ZHAO Xin.
Novel Developments in the Relationship of Gut Microbiota and Immune Regulation with Childhood Asthma [J]. Chinese General Practice, 2022, 25(08): 1021-1026.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.01.045
[1] | HAMMAD H, LAMBRECHT B N. The basic immunology of asthma[J]. Cell,2021,184(6):1469-1485. DOI:10.1016/j.cell.2021.02.016. |
[2] | 中华医学会儿科学会呼吸学组,《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南[J]. 中华儿科杂志,2008,46(10):745-753. DOI:10.3321/j.issn:0578-1310.2008.10.006. |
[3] | PLUNKETT C H, NAGLER C R. The influence of the microbiome on allergic sensitization to food[J]. J Immunol,2017,198(2):581-589. DOI:10.4049/jimmunol.1601266. |
[4] | ARRIETA M C, STIEMSMA L T, DIMITRIU P A,et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma[J]. Sci Transl Med,2015,7(307):307ra152. DOI:10.1126/scitranslmed.aab2271. |
[5] | CESTA M F. Normal structure,function,and histology of mucosa-associated lymphoid tissue[J]. Toxicol Pathol,2006,34(5):599-608. DOI:10.1080/01926230600865531. |
[6] | CHARLSON E S, DIAMOND J M, BITTINGER K,et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant[J]. Am J Respir Crit Care Med,2012,186(6):536-545. DOI:10.1164/rccm.201204-0693OC. |
[7] | KAYAMA H, OKUMURA R, TAKEDA K. Interaction between the microbiota,epithelia,and immune cells in the intestine[J]. Annu Rev Immunol,2020,38:23-48. DOI:10.1146/annurev-immunol-070119-115104. |
[8] | KLOSE C S, ARTIS D. Innate lymphoid cells as regulators of immunity,inflammation and tissue homeostasis[J]. Nat Immunol,2016,17(7):765-774. DOI:10.1038/ni.3489. |
[9] | JOERIS T, MÜLLER-LUDA K, AGACE W W,et al. Diversity and functions of intestinal mononuclear phagocytes[J]. Mucosal Immunol,2017,10(4):845-864. DOI:10.1038/mi.2017.22. |
[10] | SODERHOLM A T, PEDICORD V A. Intestinal epithelial cells:at the interface of the microbiota and mucosal immunity[J]. Immunology,2019,158(4):267-280. DOI:10.1111/imm.13117. |
[11] | ALLAM-NDOUL B, CASTONGUAY-PARADIS S, VEILLEUX A. Gut microbiota and intestinal trans-epithelial permeability[J]. Int J Mol Sci,2020,21(17):E6402. DOI:10.3390/ijms21176402. |
[12] | LONG H Y. Esculetin attenuates Th2 and Th17 responses in an ovalbumin-induced asthmatic mouse model[J]. Inflammation,2016,39(2):735-743. DOI:10.1007/s10753-015-0300-4. |
[13] | SACKS D, BAXTER B, CAMPBELL B C V,et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke [J]. Int J Stroke,2018,13(6):612-632. DOI:10.1177/1747493018778713. |
[14] | LINHART B, FREIDL R, ELISYUTINA O,et al. Molecular approaches for diagnosis,therapy and prevention of cow's milk allergy[J]. Nutrients,2019,11(7):E1492. DOI:10.3390/nu11071492. |
[15] | WANG S J, SHARKEY K A, MCKAY D M. Modulation of the immune response by helminths:a role for serotonin?[J]. Biosci Rep,2018,38(5):BSR20180027. DOI:10.1042/BSR20180027. |
[16] | CHIGBU D I, LOONAWAT R, SEHGAL M,et al. Hepatitis C virus infection:Host-Virus interaction and mechanisms of viral persistence[J]. Cells,2019,8(4):E376. DOI:10.3390/cells8040376. |
[17] | IVANOV I I, ATARASHI K, MANEL N,et al. Induction of intestinal Th17 cells by segmented filamentous bacteria[J]. Cell,2009,139(3):485-498. DOI:10.1016/j.cell.2009.09.033. |
[18] | ATARASHI K, TANOUE T, SHIMA T,et al. Induction of colonic regulatory T cells by indigenous Clostridium species[J]. Science,2011,331(6015):337-341. DOI:10.1126/science.1198469. |
[19] | MAZMANIAN S K, LIU C H, TZIANABOS A O,et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system[J]. Cell,2005,122(1):107-118. DOI:10.1016/j.cell.2005.05.007. |
[20] | ELENIUS V, PALOMARES O, WARIS M,et al. The relationship of serum vitamins A,D,E and LL-37 levels with allergic status,tonsillar virus detection and immune response[J]. PLoS One,2017,12(2):e0172350. DOI:10.1371/journal.pone.0172350. |
[21] | GAUVREAU G M, O'BYRNE P M, BOULET L P,et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses[J]. N Engl J Med,2014,370(22):2102-2110. DOI:10.1056/nejmoa1402895. |
[22] | WYPYCH T P, PATTARONI C, PERDIJK O,et al. Microbial metabolism of L-tyrosine protects against allergic airway inflammation[J]. Nat Immunol,2021,22(3):279-286. DOI:10.1038/s41590-020-00856-3. |
[23] | BOONPIYATHAD T, SÖZENER Z C, SATITSUKSANOA P,et al. Immunologic mechanisms in asthma[J]. Semin Immunol,2019,46:101333. DOI:10.1016/j.smim.2019.101333. |
[24] | WALKER J A, MCKENZIE A N J. TH2 cell development and function[J]. Nat Rev Immunol,2018,18(2):121-133. DOI:10.1038/nri.2017.118. |
[25] | GON Y, HASHIMOTO S. Role of airway epithelial barrier dysfunction in pathogenesis of asthma[J]. Allergol Int,2018,67(1):12-17. DOI:10.1016/j.alit.2017.08.011. |
[26] | HUANG Y F, MAO K R, CHEN X,et al. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense[J]. Science,2018,359(6371):114-119. DOI:10.1126/science.aam5809. |
[27] | GASTEIGER G, FAN X Y, DIKIY S,et al. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs[J]. Science,2015,350(6263):981-985. DOI:10.1126/science.aac9593. |
[28] | GRAY J, OEHRLE K, WORTHEN G,et al. Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection[J]. Sci Transl Med,2017,9(376):eaaf9412. DOI:10.1126/scitranslmed.aaf9412. |
[29] | BRADLEY C P, TENG F, FELIX K M,et al. Segmented filamentous bacteria provoke lung autoimmunity by inducing gut-lung axis Th17 cells expressing dual TCRs[J]. Cell Host Microbe,2017,22(5):697-704.e4. DOI:10.1016/j.chom.2017.10.007. |
[30] | ICHINOHE T, PANG I K, KUMAMOTO Y,et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection[J]. Proc Natl Acad Sci USA,2011,108(13):5354-5359. DOI:10.1073/pnas.1019378108. |
[31] | QIAN G J, JIANG W, ZOU B K,et al. LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma[J]. J Exp Med,2018,215(9):2397-2412. DOI:10.1084/jem.20172225. |
[32] | ANAND S, MANDE S S. Diet,microbiota and gut-lung connection[J]. Front Microbiol,2018,9:2147. DOI:10.3389/fmicb.2018.02147. |
[33] | BLAAK E E, CANFORA E E, THEIS S,et al. Short chain fatty acids in human gut and metabolic health[J]. Benef Microbes,2020,11(5):411-455. DOI:10.3920/BM2020.0057. |
[34] | RODUIT C, FREI R, FERSTL R,et al. High levels of butyrate and propionate in early life are associated with protection against atopy[J]. Allergy,2019,74(4):799-809. DOI:10.1111/all.13660. |
[35] | TROMPETTE A, GOLLWITZER E S, YADAVA K,et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis[J]. Nat Med,2014,20(2):159-166. DOI:10.1038/nm.3444. |
[36] | CAIT A, HUGHES M R, ANTIGNANO F,et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids[J]. Mucosal Immunol,2018,11(3):785-795. DOI:10.1038/mi.2017.75. |
[37] | SUN L C, FU J R, LIN S H,et al. Particulate matter of 2.5 μm or less in diameter disturbs the balance of TH17/regulatory T cells by targeting glutamate oxaloacetate transaminase 1 and hypoxia-inducible factor 1α in an asthma model[J]. J Allergy Clin Immunol,2020,145(1):402-414. DOI:10.1016/j.jaci.2019.10.008. |
[38] | HUFFNAGLE G B, DICKSON R P, LUKACS N W. The respiratory tract microbiome and lung inflammation:a two-way street[J]. Mucosal Immunol,2017,10(2):299-306. DOI:10.1038/mi.2016.108. |
[39] | SZE M A, TSURUTA M, YANG S W,et al. Changes in the bacterial microbiota in gut,blood,and lungs following acute LPS instillation into mice lungs[J]. PLoS One,2014,9(10):e111228. DOI:10.1371/journal.pone.0111228. |
[40] | PERRONE E E, JUNG E, BREED E,et al. Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis[J]. Shock,2012,38(1):68-75. DOI:10.1097/SHK.0b013e318259abdb. |
[41] | YOUNG R P, HOPKINS R J, MARSLAND B. The gut-liver-lung axis. modulation of the innate immune response and its possible role in chronic obstructive pulmonary disease[J]. Am J Respir Cell Mol Biol,2016,54(2):161-169. DOI:10.1165/rcmb.2015-0250PS. |
[42] | KISS E A, VONARBOURG C, KOPFMANN S,et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles[J]. Science,2011,334(6062):1561-1565. DOI:10.1126/science.1214914. |
[43] | SINGH N, GURAV A, SIVAPRAKASAM S,et al. Activation of Gpr109a,receptor for niacin and the commensal metabolite butyrate,suppresses colonic inflammation and carcinogenesis[J]. Immunity,2014,40(1):128-139. DOI:10.1016/j.immuni.2013.12.007. |
[44] | KIBE R, KURIHARA S, SAKAI Y,et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice[J]. Sci Rep,2014,4:4548. DOI:10.1038/srep04548. |
[45] | GEIGER R, RIECKMANN J C, WOLF T,et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity[J]. Cell,2016,167(3):829-842.e13. DOI:10.1016/j.cell.2016.09.031. |
[46] | ESLAMI M, BAHAR A, KEIKHA M,et al. Probiotics function and modulation of the immune system in allergic diseases[J]. Allergol Immunopathol (Madr),2020,48(6):771-788. DOI:10.1016/j.aller.2020.04.005. |
[47] | CHIU C J, HUANG M T. Asthma in the precision medicine era:biologics and probiotics[J]. Int J Mol Sci,2021,22(9):4528. DOI:10.3390/ijms22094528. |
[48] | WEI X C, JIANG P, LIU J B,et al. Association between probiotic supplementation and asthma incidence in infants:a meta-analysis of randomized controlled trials[J]. J Asthma,2020,57(2):167-178. DOI:10.1080/02770903.2018.1561893. |
[49] | GORISSEN D M W, RUTTEN N B M M, OOSTERMEIJER C M J,et al. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study[J]. Clin Exp Allergy,2014,44(11):1431-1433. DOI:10.1111/cea.12413. |
[50] | NIERS L E M, TIMMERMAN H M, RIJKERS G T,et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines[J]. Clin Exp Allergy,2005,35(11):1481-1489. DOI:10.1111/j.1365-2222.2005.02375.x. |
[51] | NIERS L E, HOEKSTRA M O, TIMMERMAN H M,et al. Selection of probiotic bacteria for prevention of allergic diseases:immunomodulation of neonatal dendritic cells[J]. Clin Exp Immunol,2007,149(2):344-352. DOI:10.1111/j.1365-2249.2007.03421.x. |
[52] | AZAD M B, CONEYS J G, KOZYRSKYJ A L,et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze:systematic review and meta-analysis[J]. BMJ,2013,347:f6471. DOI:10.1136/bmj.f6471. |
[53] | WICKENS K, STANLEY T V, MITCHELL E A,et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years:does it also reduce atopic sensitization?[J]. Clin Exp Allergy,2013,43(9):1048-1057. DOI:10.1111/cea.12154. |
[54] | KALLIOMÄKI M, SALMINEN S, POUSSA T,et al. Probiotics during the first 7 years of life:a cumulative risk reduction of eczema in a randomized,placebo-controlled trial[J]. J Allergy Clin Immunol,2007,119(4):1019-1021. DOI:10.1016/j.jaci.2006.12.608. |
[55] | KUITUNEN M, KUKKONEN K, JUNTUNEN-BACKMAN K,et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort[J]. J Allergy Clin Immunol,2009,123(2):335-341. DOI:10.1016/j.jaci.2008.11.019. |
[56] | BOYLE R J, ISMAIL I H, KIVIVUORI S,et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema:a randomized controlled trial[J]. Allergy,2011,66(4):509-516. DOI:10.1111/j.1398-9995.2010.02507.x. |
[57] | WEST C E, HAMMARSTRÖM M L, HERNELL O. Probiotics in primary prevention of allergic disease-follow-up at 8-9 years of age[J]. Allergy,2013,68(8):1015-1020. DOI:10.1111/all.12191. |
[58] | ABRAHAMSSON T R, JAKOBSSON T, BJÖRKSTÉN B,et al. No effect of probiotics on respiratory allergies:a seven-year follow-up of a randomized controlled trial in infancy[J]. Pediatr Allergy Immunol,2013,24(6):556-561. DOI:10.1111/pai.12104. |
[59] | KAUPPI P, KUOKKA NEN M, KUKKONEN K,et al. Interaction of NPSR1 genotypes and probiotics in the manifestation of atopic eczema in early childhood[J]. Allergol Immunopathol(Madr),2014,42(6):560-567. DOI:10.1016/j.aller.2013.10.001. |
[60] | LOO E X L, LLANORA G V, LU Q S,et al. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants:a 5-year follow-up[J]. Int Arch Allergy Immunol,2014,163(1):25-28. DOI:10.1159/000356338. |
[61] | BERNI CANANI R, DI COSTANZO M, BEDOGNI G,et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy:3-year randomized controlled trial[J]. J Allergy Clin Immunol,2017,139(6):1906-1913.e4. DOI:10.1016/j.jaci.2016.10.050. |
[62] | CABANA M D, MCKEAN M, CAUGHEY A B,et al. Early probiotic supplementation for eczema and asthma prevention:a randomized controlled trial[J]. Pediatrics,2017,140(3):e20163000. DOI:10.1542/peds.2016-3000. |
[63] | FELESZKO W, JAWORSKA J, RHA R D,et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma[J]. Clin Exp Allergy,2007,37(4):498-505. DOI:10.1111/j.1365-2222.2006.02629.x. |
[64] | SPACOVA I, VAN BEECK W, SEYS S,et al. Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model[J]. Gut Microbes,2020,11(6):1729-1744. DOI:10.1080/19490976.2020.1766345. |
[65] | KARIMI K, INMAN M D, BIENENSTOCK J,et al. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice[J]. Am J Respir Crit Care Med,2009,179(3):186-193. DOI:10.1164/rccm.200806-951OC. |
[66] | WANG X F, HUI Y, ZHAO L,et al. Oral administration of Lactobacillus paracasei L9 attenuates PM2.5-induced enhancement of airway hyperresponsiveness and allergic airway response in murine model of asthma[J]. PLoS One,2017,12(2):e0171721. DOI:10.1371/journal.pone.0171721. |
[67] | KAWAHARA T, TAKAHASHI T, OISHI K,et al. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model[J]. Microbiol Immunol,2015,59(1):1-12. DOI:10.1111/1348-0421.12210. |
[68] | WU C T, CHEN P J, LEE Y T,et al. Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model[J]. J Microbiol Immunol Infect,2016,49(5):625-635. DOI:10.1016/j.jmii.2014.08.001. |
[69] | CERVANTES-GARCÍA D, JIMÉNEZ M, RIVAS-SANTIAGO C E,et al. Lactococcus lactis NZ9000 prevents asthmatic airway inflammation and remodelling in rats through the improvement of intestinal barrier function and systemic TGF-β production[J]. Int Arch Allergy Immunol,2021,182(4):277-291. DOI:10.1159/000511146. |
[70] | RACEDO S, VILLENA J, MEDINA M,et al. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice[J]. Microbes Infect,2006,8(9/10):2359-2366. DOI:10.1016/j.micinf.2006.04.022. |
[71] | HORI T, KIYOSHIMA J, SHIDA K,et al. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota[J]. Clin Diagn Lab Immunol,2002,9(1):105-108. DOI:10.1128/cdli.9.1.105-108.2002. |
[72] | TAKEDA S, TAKESHITA M, KIKUCHI Y,et al. Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice:alleviation of influenza infection by its immunomodulatory activity through intestinal immunity[J]. Int Immunopharmacol,2011,11(12):1976-1983. DOI:10.1016/j.intimp.2011.08.007. |
[73] | ZELAYA H, TADA A, VIZOSO-PINTO M G,et al. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage[J]. Inflamm Res,2015,64(8):589-602. DOI:10.1007/s00011-015-0837-6. |
[1] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[2] | YIN Zhaoxia, MAO Lidong, ZHANG Baoshuang, HUANG Yin, FENG Yang, WANG Yunfei. Spectrum of Outpatient Illnesses in Children Contracting Family Doctor Services in Shenzhen's Community Settings and Related Implications for Standardized Residency Training of General Practitioners [J]. Chinese General Practice, 2023, 26(33): 4218-4224. |
[3] | WANG Xu, WEI Xu, ZHU Liguo, FENG Tianxiao, WANG Zhipeng, SHI Bin. Research Ideas of the Efficacy Mechanism and Prospect Analysis of Traditional Chinese Manipulative Therapy on Treating Spinal Degenerative Diseases with Combination of Medicine and Industry [J]. Chinese General Practice, 2023, 26(33): 4118-4124. |
[4] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[5] | ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117. |
[6] | MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102. |
[7] | WANG Jiaxin, ZHAO Yali. Domestic and International Assessment Tools for Medical Teamwork: a Systematic Review [J]. Chinese General Practice, 2023, 26(31): 3951-3962. |
[8] | WEI Mengyu, WANG Jiajia, ZHANG Yingying, LI Chunyang, LI Jiansheng. Research Status of Patient-reported Outcome Assessment Tools for Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3725-3733. |
[9] | SHI Xiaoqi, LUO Nandu, HUANG Jiaojiao, DU Zuochen, HUANG Pei, CAO Xiuli, CHEN Yan, HE Zhixu. Correlation between Aspartate Aminotransferase/Alanine Aminotransferase and Prognosis of Hemophagocytic Lymphohistiocytosis in Children [J]. Chinese General Practice, 2023, 26(30): 3801-3808. |
[10] | YUAN Xiwei, NAN Yuemin. Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases [J]. Chinese General Practice, 2023, 26(30): 3841-3846. |
[11] | CHENG Jingwei, QIAO Junjun, YIN Zhen, HU Junpeng, WANG Qinghe, LIU Yangqing, WANG Yanfang. Interpretation of ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes [J]. Chinese General Practice, 2023, 26(30): 3719-3724. |
[12] | XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840. |
[13] | LIU Yu, YUE Ting, YANG Dongyu, ZHAO Zhongting, YANG Jibo, ZHU Tiantian. Research Progress on Mechanism of Autophagy in the Pathogenesis of Rheumatoid Arthritis [J]. Chinese General Practice, 2023, 26(29): 3710-3714. |
[14] | ZHANG Zhendong, CAI Bin, WANG Hongwei, QIAO Zengyong. Study on the Changes of Intestinal Flora and Its Metabolite Phenylacetylglutamine in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2023, 26(29): 3665-3673. |
[15] | PU Yu, ZHANG Jixiang, DONG Weiguo. Advances in Ferroptosis and Inflammatory Bowel Disease [J]. Chinese General Practice, 2023, 26(29): 3698-3703. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||